IDXX

Idexx Laboratories Stock Analysis

AI Rating

Neutral
  • Quality7/10
  • Growth 5/10
  • Value 1/10
Idexx Laboratories sales and earnings growth
IDXX Growth
Neutral
  • Revenue Y/Y 10.42%
  • EPS Y/Y 22.28%
  • FCF Y/Y 30.76%
Idexx Laboratories gross and profit margin trends
IDXX Profitability
Great
  • Gross margin 61.80%
  • EPS margin 24.60%
  • ROIC 5Y 46.43%
Idexx Laboratories net debt vs free cash flow
IDXX Risk
Great
  • Debt / Equity 0.6
  • Debt / FCF 0.7
  • Interest coverage 35.1

Idexx Laboratories stock volatility is in-line with the overall market. We give it a Great risk rating.

More Diagnostics & Research stocks ↗